Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates
Clinical trial NCT01484080 · COMPLETED
Trial details
- NCT number
- NCT01484080
- Sponsor
- Centro Nacional de Investigaciones Oncologicas CARLOS III
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2013-11-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.